Female Libido Enhancement for Improved Sexual Satisfaction
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.55 | $49.20 (0%) | 🛒 Add to cart |
| 120 | $0.50 | $65.60 $60.24 (8%) | 🛒 Add to cart |
| 180 | $0.47 | $98.40 $84.34 (14%) | 🛒 Add to cart |
| 270 | $0.44 | $147.59 $118.48 (20%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $196.79 $153.62 (22%) | 🛒 Add to cart |
Female libido enhancement represents a significant advancement in addressing Hypoactive Sexual Desire Disorder (HSDD) and other forms of female sexual dysfunction. This pharmaceutical intervention is specifically formulated to target neurochemical pathways involved in sexual response, offering a clinically validated approach to improving sexual desire, arousal, and overall sexual satisfaction. Developed through rigorous research and clinical trials, this treatment provides women with a safe and effective option for reclaiming their sexual health and intimacy.
Features
- Contains flibanserin 100mg as the active pharmaceutical ingredient
- Non-hormonal mechanism of action targeting serotonin receptors
- FDA-approved for premenopausal women with HSDD
- Once-daily oral administration regimen
- Requires prescription and medical supervision
- Clinical trial data demonstrating efficacy in improving sexual desire
- Standardized manufacturing following cGMP guidelines
- Child-resistant packaging with clear dosage instructions
Benefits
- Increases spontaneous sexual thoughts and fantasies
- Enhances overall sexual satisfaction and intimacy
- Reduces distress associated with low sexual desire
- Improves relationship quality and emotional connection
- Provides a medically supervised treatment option
- Offers long-term management of HSDD symptoms
Common use
This medication is primarily prescribed for premenopausal women diagnosed with acquired, generalized Hypoactive Sexual Desire Disorder (HSDD), characterized by persistently low sexual desire that causes marked distress or interpersonal difficulty. It is not indicated for sexual dysfunction due to coexisting medical or psychiatric conditions, relationship problems, or the effects of substance abuse. Healthcare providers typically recommend this treatment after comprehensive evaluation and exclusion of other causes of decreased libido, including hormonal imbalances, medication side effects, or underlying health conditions.
Dosage and direction
The standard dosage is one 100mg tablet taken orally once daily at bedtime. Administration at bedtime is crucial due to the potential for dizziness, sleepiness, and fatigue. Patients should not consume alcohol within two hours before or after taking the medication due to increased risk of severe hypotension and syncope. Treatment response typically becomes apparent after 4-8 weeks of consistent use, though some patients may require longer duration. Dosage adjustments are not recommended, and the medication should be taken at approximately the same time each evening to maintain stable plasma concentrations.
Precautions
Patients should undergo thorough medical evaluation before initiation, including assessment of liver function, blood pressure monitoring, and review of concomitant medications. Regular follow-up appointments are essential to monitor treatment response and potential side effects. Women should use effective contraception during treatment, as safety during pregnancy has not been established. Caution is advised when operating machinery or engaging in activities requiring alertness, particularly during the initial treatment phase. Patients with a history of depression or mood disorders require close monitoring, as the medication affects serotonin pathways.
Contraindications
This medication is contraindicated in patients with hepatic impairment, those taking strong CYP3A4 inhibitors, and individuals with a history of hypersensitivity to flibanserin or any component of the formulation. Concurrent use with alcohol is strictly prohibited due to the risk of severe hypotension and syncope. The medication is not approved for use in postmenopausal women or men. Patients with a history of hypotension, syncope, cardiovascular disease, or psychiatric disorders requiring medication may require alternative treatment approaches.
Possible side effects
Common adverse reactions include dizziness (11.4%), somnolence (11.2%), nausea (10.4%), fatigue (9.2%), and insomnia (4.9%). Less frequent side effects may include dry mouth, anxiety, and hypotension. Serious but rare adverse events include syncope (0.4%), hypotension (0.2%), and central nervous system depression. Most side effects are dose-dependent and tend to diminish with continued use. Patients should report persistent or severe side effects to their healthcare provider immediately.
Drug interaction
Significant interactions occur with moderate and strong CYP3A4 inhibitors, including fluconazole, verapamil, and erythromycin, which may increase flibanserin exposure. Concurrent use with other central nervous system depressants, including benzodiazepines, opioids, and sleep aids, may potentiate sedation effects. Serotonergic drugs, including SSRIs and SNRIs, may increase the risk of serotonin syndrome. Healthcare providers must conduct comprehensive medication reconciliation before prescribing and monitor for interactions throughout treatment.
Missed dose
If a dose is missed, patients should skip that dose and resume the regular dosing schedule the following evening. Doubling the dose to make up for a missed tablet is not recommended due to increased risk of adverse effects. Patients should maintain the regular dosing schedule and contact their healthcare provider if multiple doses are missed or if they have questions about dosage management.
Overdose
Symptoms of overdose may include severe dizziness, profound sedation, hypotension, and syncope. In case of suspected overdose, immediate medical attention is required. Treatment is supportive and may include monitoring of vital signs, ECG monitoring, and management of hypotension with intravenous fluids. There is no specific antidote for flibanserin overdose. Gastric lavage or activated charcoal may be considered if ingestion occurred within a short time frame.
Storage
Store at room temperature (20-25°C or 68-77°F) in the original container, protected from light and moisture. Keep out of reach of children and pets. Do not transfer tablets to other containers, as the original packaging provides protection from environmental factors. Discard any medication that has expired or shows signs of deterioration. Proper disposal methods should follow local regulations for pharmaceutical waste.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. The medication should only be used under the supervision of a qualified healthcare professional. Individual results may vary, and not all patients will experience the same benefits. Patients should discuss their specific medical situation, potential risks, and treatment alternatives with their healthcare provider before initiating therapy.
Reviews
Clinical studies demonstrate that approximately 50-60% of women treated with flibanserin experience meaningful improvement in sexual desire and distress scores. Patient-reported outcomes indicate increased satisfaction with sexual activity and improved emotional connection with partners. However, individual responses vary, and some patients may not achieve desired results. Long-term follow-up data shows sustained efficacy with continued use, though regular medical supervision remains essential for optimal outcomes and safety monitoring.